Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Dare Bioscience (DARE) Long-Term Debt Repayments (2016 - 2025)

Dare Bioscience's Long-Term Debt Repayments history spans 8 years, with the latest figure at $182521.0 for Q4 2025.

For Q4 2025, Long-Term Debt Repayments fell 2.51% year-over-year to $182521.0; the TTM value through Dec 2025 reached $553829.0, down 4.38%, while the annual FY2025 figure was $553829.0, 4.38% down from the prior year.
Long-Term Debt Repayments reached $182521.0 in Q4 2025 per DARE's latest filing, up from $121680.0 in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $200391.0 in Q4 2023 to a low of $62407.0 in Q2 2025.
Average Long-Term Debt Repayments over 3 years is $146703.7, with a median of $158057.5 recorded in 2023.
Peak YoY movement for Long-Term Debt Repayments: fell 6.57% in 2024, then decreased 2.51% in 2025.
A 3-year view of Long-Term Debt Repayments shows it stood at $200391.0 in 2023, then fell by 6.57% to $187221.0 in 2024, then dropped by 2.51% to $182521.0 in 2025.
Per Business Quant, the three most recent readings for DARE's Long-Term Debt Repayments are $182521.0 (Q4 2025), $121680.0 (Q3 2025), and $62407.0 (Q2 2025).